302 related articles for article (PubMed ID: 29126891)
1. Early, real-world experience with direct oral anticoagulants in the treatment of intermediate-high risk acute pulmonary embolism.
Santos SM; Cunha S; Baptista R; Monteiro S; Monteiro P; Gonçalves F; Pêgo M
Rev Port Cardiol; 2017 Nov; 36(11):801-806. PubMed ID: 29126891
[TBL] [Abstract][Full Text] [Related]
2. Direct oral anticoagulants in the treatment of venous thromboembolism, with a focus on patients with pulmonary embolism: an evidence-based review.
Gómez-Outes A; Suárez-Gea ML; Lecumberri R; Terleira-Fernández AI; Vargas-Castrillón E
Vasc Health Risk Manag; 2014; 10():627-39. PubMed ID: 25404858
[TBL] [Abstract][Full Text] [Related]
3. Reducing length of stay with the direct oral anti-coagulants in low and intermediate risk pulmonary embolism: a single center experience.
Filopei J; Bondarsky EE; Ehrlich M; Islam M; Bajpayee G; Pang D; Shujaat A; Rowland J; Steiger DJ
J Thromb Thrombolysis; 2020 Aug; 50(2):399-407. PubMed ID: 31997255
[TBL] [Abstract][Full Text] [Related]
4. Prescription patterns of direct oral anticoagulants in pulmonary embolism: A prospective multicenter French registry.
Chopard R; Andarelli JN; Humbert S; Falvo N; Morel-Aleton M; Bonnet B; Napporn G; Kalbacher E; Obert L; Degano B; Cappelier G; Cottin Y; Schiele F; Meneveau N
Thromb Res; 2019 Feb; 174():27-33. PubMed ID: 30553162
[TBL] [Abstract][Full Text] [Related]
5. Intracranial Hemorrhage in Deep Vein Thrombosis/Pulmonary Embolus Patients Without Atrial Fibrillation.
Lamsam L; Sussman ES; Iyer AK; Bhambhvani HP; Han SS; Skirboll S; Ratliff JK
Stroke; 2018 Aug; 49(8):1866-1871. PubMed ID: 29991654
[TBL] [Abstract][Full Text] [Related]
6. Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism.
Ghazvinian R; Gottsäter A; Elf JL
J Thromb Thrombolysis; 2018 Feb; 45(2):319-324. PubMed ID: 29305675
[TBL] [Abstract][Full Text] [Related]
7. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
8. Initiation of direct oral anticoagulants versus warfarin for venous thromboembolism: impact on time to hospital discharge.
Basto AN; Fewel NP; Vo K; Stock EM; Ta M
J Thromb Thrombolysis; 2018 Jan; 45(1):51-55. PubMed ID: 29086244
[TBL] [Abstract][Full Text] [Related]
9. Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events.
Chopard R; Serzian G; Humbert S; Falvo N; Morel-Aleton M; Bonnet B; Napporn G; Kalbacher E; Obert L; Degano B; Cappelier G; Cottin Y; Schiele F; Meneveau N
J Thromb Thrombolysis; 2018 Oct; 46(3):283-291. PubMed ID: 29869319
[TBL] [Abstract][Full Text] [Related]
10. Early prescription of direct oral anticoagulant for the treatment of intermediate-high risk pulmonary embolism: a multi-center, observational cohort study.
Chopard R; Badoz M; Eveno C; Ecarnot F; Falvo N; Kalbacher E; Capellier G; Guillon B; Schiele F; Meneveau N
Thromb Res; 2020 Dec; 196():476-482. PubMed ID: 33091699
[TBL] [Abstract][Full Text] [Related]
11. Hospital length of stay in patients initiated on direct oral anticoagulants versus warfarin for venous thromboembolism: a real-world single-center study.
Badreldin H
J Thromb Thrombolysis; 2018 Jul; 46(1):16-21. PubMed ID: 29626281
[TBL] [Abstract][Full Text] [Related]
12. Six Months vs Extended Oral Anticoagulation After a First Episode of Pulmonary Embolism: The PADIS-PE Randomized Clinical Trial.
Couturaud F; Sanchez O; Pernod G; Mismetti P; Jego P; Duhamel E; Provost K; dit Sollier CB; Presles E; Castellant P; Parent F; Salaun PY; Bressollette L; Nonent M; Lorillon P; Girard P; Lacut K; Guégan M; Bosson JL; Laporte S; Leroyer C; Décousus H; Meyer G; Mottier D;
JAMA; 2015 Jul; 314(1):31-40. PubMed ID: 26151264
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of anticoagulation selection for acute venous thromboembolism.
Badreldin H; Nichols H; Rimsans J; Carter D
J Thromb Thrombolysis; 2017 Jan; 43(1):74-78. PubMed ID: 27592341
[TBL] [Abstract][Full Text] [Related]
14. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
[TBL] [Abstract][Full Text] [Related]
15. Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism.
Weeda ER; Kohn CG; Peacock WF; Fermann GJ; Crivera C; Schein JR; Coleman CI
Pharmacotherapy; 2016 Oct; 36(10):1109-1115. PubMed ID: 27548074
[TBL] [Abstract][Full Text] [Related]
16. Apixaban or Rivaroxaban Versus Warfarin for Treatment of Submassive Pulmonary Embolism After Catheter-Directed Thrombolysis.
Groetzinger LM; Miller TJ; Rivosecchi RM; Smith RE; Gladwin MT; Rivera-Lebron BN
Clin Appl Thromb Hemost; 2018 Sep; 24(6):908-913. PubMed ID: 29455567
[TBL] [Abstract][Full Text] [Related]
17. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism.
Wolfe A; Phillips A; Tierney DM; Melamed R; Qadri G; Lillyblad M; Smith C; St Hill C; Stenzel AE; Beddow D; Kirven J; Kethireddy R; Patel L
Clin Appl Thromb Hemost; 2023; 29():10760296231156414. PubMed ID: 36890702
[TBL] [Abstract][Full Text] [Related]
19. Anticoagulant therapies for acute venous thromboembolism among a cohort of patients discharged from Canadian urban and rural hospitals.
Bungard TJ; Ritchie B; Bolt J; Semchuk WM
BMJ Open; 2018 Oct; 8(10):e022065. PubMed ID: 30385440
[TBL] [Abstract][Full Text] [Related]
20. Acute Pulmonary Embolism after Discharge: Duration of Therapy and Follow-up Testing.
Becattini C; Franco L; Agnelli G
Semin Respir Crit Care Med; 2017 Feb; 38(1):94-106. PubMed ID: 28208203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
